Good news for people looking for more affordable options to help them lose weight and keep it off! The U.S. Food and Drug Administration (FDA) approved a generic version of Saxenda, a commonly prescribed glucagon-like peptide-1 receptor agonist (GLP-1). “With this approval, and by launching a generic for Saxenda (liraglutide injection), we will provide patients […] The post FDA approves generic Saxenda appeared first on The Checkup.
